No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: Is there a way? A prospective analysis of our approach

Archives of Surgery

Volumn 134, Issue 9, 1999, Pages 984-992

  Torzilli, Guido ^a   Makuuchi, Masatoshi ^a   Inoue, Kazuto ^a   Takayama, Tadatoshi ^a   Sakamoto, Yoshihiro ^a   Sugawara, Yasuhiko ^a   Kubota, Keiichi ^a   Zucchi, Alberto ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Hospital of Lodi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032870752     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.9.984     Document Type: Article

References (80)

1. Parkin DM, Stjernward J, Muir CS. Estimates of the world-wide frequency of twelve major cancers. Bull World Health Organ. 1984;63:163-182.
2. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325:675-680.
3. Okuda K, Okuda H. Primary liver cell carcinoma. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Vol 2. New York, NY: Oxford University Press Inc; 1991:1019-1052.
4. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for hepatocellular carcinoma. Cancer, 1990;65:1104-1110.
5. Nonami T, Harada A, Kurokawa T, et al. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173:288-291.
6. Marcos-Alvarez A, Jenkins RL, Washbum K, et al. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg. 1996;131: 292-298.
7. Izumi R, Shimizu K, Ii T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106:720-727.
8. Kawarada Y, Ito F, Sakurai H, et al. Surgical treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol. 1994;33(suppl):S12-S17.
9. Kim ST, Kim KP. Hepatic resections for primary liver cancer. Cancer Chemother Pharmacol. 1994;33(suppl):S18-S23.
10. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298-304.
11. Couinaud C. Le Foie: Etude Anatomiques et Chirurgicales. New York, NY: Masson Publishing; 1957.
12. Makuuchi M, Hasegawa H, Yamazaki S. Indication for hepatectomy in patients with hepatocellular carcinoma and cirrhosis. Shindan To Chiryo. 1986;74:1225-1230.
13. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997:26:1176-1181.
14. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:541-549.
15. Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155-158.
16. Hu RH, Lee PH, Yu SC, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery. 1996;120:23-29.
17. Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Am Surg. 1995;221:291-298.
18. Sitzmann JV, Greene PS. Perioperative predictors of morbidity following hepatic resection for neoplasm: a multivariate analysis of a single surgeon experience with 105 patients. Am Surg. 1994:219:13-17.
19. Holbrook RF, Koo K, Ryan JA. Resection of malignant primary liver tumors. Am J Surg. 1996:171:453-455.
20. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994;219:236-247.
21. Veenok AP. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol. 1994:12:1323-1334.
22. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334:693-699.
23. Ringe B, Pichlmayr R, Wittekind C, Tush G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 19 patients. World J Surg. 1991;15:270-285.
24. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221-229.
25. Marsh JW, Dvoechik I, Subotin M, et al. The prediction of risk of recurrence and time of recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology, 1997;26:444-450.
26. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer. 1992;68:925-929.
27. Otsuka S. Percutaneous microwave coagulation therapy and endoscopic microwave coagulonecrotic therapy for small hepatocellular carcinoma. Nippon Rinsho. 1996;54:1343-1346.
28. Urata K, Uehara S, Hayashi H, et al. Radiofrequency hyperthermia for malignant liver tumors: the clinical results of seven patients. Hepatogastroenterology. 1995; 42:492-496.
29. Honda N, Guo O, Uchida H, et al. Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therap. Radiology. 1994;190:53-57.
30. Kanematsu T, Matsumata T, Shirabe K, et al. A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer. 1993;71:2181-2186.
31. Shiina S, Niwa Y. Percutaneous ethanol injection therapy in the treatment of liver neoplasms. In: Howard E, ed. Current Techniques in Interventional Radiology. Philadelphia, Pa: Cope C; 1994:3.1-3.14.
32. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995; 197:101-108.
33. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995;108:768-775.
34. Arii S, Tanaka J, Yamazo Y, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer. 1992;69:913-919.
35. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1992;214:114-117.
36. Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery. 1993;113:612-618.
37. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219-1222.
38. Okuda K. Intratumor ethanol injection. J Surg Oncol. 1993;3(suppl):97-99.
39. Castellano L, Calandra M, Del Vecchio Bianco C, De Sio I. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol. 1997;27: 862-870.
40. Tanikawa K. Multidisciplinary treatment of hepatocellular carcinoma. In: Tobe T, Kameda H, eds. Primary Liver Cancer in Japan. New York, NY: Springer-Verlag NY Inc; 1992:327.
41. Liver Cancer Study Group of Japan. Survey and follow-up of primary cancer in Japan: report 12. Acta Hepatol Jpn. 1997;38:35-48.
42. Makuuchi M, Takayama T, Kosuge T, et al. The value of ultrasonography for hepatic surgery. Hepatogastroenterology. 1991;38:64-70.
43. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589-594.
44. Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300-1306.
45. Fan ST, Lo CM, Lai EC, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331:1547-1552.
46. Oka H, Yamamoto S, Kuroki T, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Shosaiko-to (TJ-9). Cancer. 1995;76:743-749.
47. Noun R, Jagot P, Farges O, et al. High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A patients. World J Surg 1997;21:390-394.
48. Makuuchi M, Le Thai B, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521-527.
49. Kawasaki S, Makuuchi M, Kakazu T. Resection for multiple metastatic liver tumors after portal embolization. Surgery. 1994;115:674-677.
50. Azoulay D, Raccuia JS, Castaign D, et al. Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg. 1995;181:267-269.
51. De Baere T, Roche A, Elias D, et al. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996;24:1386-1391.
52. Makuuchi M, Yamamoto J, Takayama T, et al. Extrahepatic division of the right hepatic vein in hepatectomy. Hepatogastroenterology. 1991;38:176-179.
53. Lai EC, Fan ST, Lo CM, et al. Anterior approach for difficult major right hepatectomy. World J Surg. 1996;20:314-317.
54. Makuuchi M, Hasegawa H, Yamazaki S. Four new hepatectomy procedures for resection of the right hepatic vein and preservation of the inferior right hepatic vein. Surg Gynecol Obstet. 1987;164:68-72.
55. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985;161:346-350.
56. Nagourney DM, Van Heerden JA, Ilstrup DM, Adson MA. Primary hepatic malignancies: surgical management and determinants of survival. Surgery. 1989; 106:740-749.
57. Jamieson GG, Corbel L, Campion JP, et al. Major liver resection without blood transfusions: is it a realistic objective? Surgery. 1992;112:32-36.
58. Makuuchi M, Takayama T, Gunven P.et al. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg. 1989;13: 644-648.
59. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994; 115:303-309.
60. Fan ST, Lai ECS, Lo CM, et al. Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg. 1996;83:117-120.
61. Mariette D, Smadja C, Noveau S, et al. Preoperative predictors of blood transfusion in liver resections for tumor. Am J Surg. 1997;173:275-279.
62. Wu CC, Hwang CR, Liu TJ, Peng FK. Effects and limitations of prolonged intermittent ischemia for hepatic resection of the cirrhotic liver. Br J Surg. 1996;86: 121-124.
63. Man K, Fan ST, Ng IOL, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997:226:704-713.
64. Rees M, Plant G, Wells J, Bygrave S. One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery. Br J Surg. 1996;83:1526-1529.
65. Franco D, Karaa A, Meakins JL, et al. Hepatectomy without abdominal drainage: results of a prospective study in 61 patients. Ann Surg. 1989;210:748-750.
66. Fong Y, Brennan MF, Brown K, et al. Drainage is unnecessary after elective liver resection. Am J Surg. 1996;171:158-162.
67. Bona S, Gavelli A, Huguet C. The role of abdominal drainage after major liver resection. Am J Surg. 1994;167:593-595.
68. Makuuchi M. Segmentectomy and subsegmentectomy. In: Lygidakis NJ, Makuuchi M, eds. Pitfalls and Complications in the Diagnosis and Management of Hepatobiliary and Pancreatic Diseases. Stuttgart, Germany: Georg Thieme Verlag; 1993: 133-145.
69. Ziegler TR. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. J Parenter Enter Nutr. 1996;20:91-92.
70. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg. 1997;173:358-365.
71. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: a multicenter survey of evaluation practices and complications rates. Scand J Gastroenterol. 1997;32:1168-1173.
72. Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer. 1998;83:48-57.
73. Kurl S, Farin P, Rytkonem H, et al. Intraperitoneal seeding from hepatocellular carcinoma following ethanol ablation therapy. Abdom Imaging. 1997;22:201-203.
74. Takayama T, Makuuchi M. Surgical resection. In: Livraghi T, Makuuchi M, Buscarini L, eds. Diagnosis and Treatment of Hepatocellular Carcinoma. London, England: Greenwich Medical Media; 1997:279-294.
75. Yamaoka Y, Kumada K, Ino K, et al. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein. World J Surg. 1992;16:1172-1177.
76. Nagasue N, Kohno H, Hayashio T, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg. 1996;83:127-131.
77. Yamaoka Y, Ozawa K, Kumada K, et al. Total vascular exclusion for hepatic resection in cirrhotic patients: application of venovenous bypass. Arch Surg. 1992; 127:276-280.
78. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med. 1996;334:1561-1567.
79. Tanaka K, Sata M, Uchimura Y, et al. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma? Oncol Rep. 1998;5:205-208.
80. Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989;96:527-529.